DOTTIKON ES HLDG revenue for the last year amounted to 395.30 M CHF, the most of which — 326.27 M CHF — came from its highest performing source at the moment, Chemicals, Intermediates, and Exclusive Active Pharmaceutical Ingredients, the year earlier bringing 319.45 M CHF. The greatest contribution to the revenue figure was made by Switzerland — last year it brought DOTTIKON ES HLDG 326.27 M CHF, and the year before that — 319.45 M CHF.